TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial.

Yanfen Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.